Download PDF
Zentralbl Chir 2007; 132(4): 293-299
DOI: 10.1055/s-2007-981198
Originalarbeiten und Übersichten

© Georg Thieme Verlag Stuttgart · New York

Interventionelle, laparoskopische und offen operative Radiofrequenztherapie maligner Leberläsionen

Percutaneous, Laparoscopic and Open Surgical Radiofrequency Ablation of Malignant Liver LesionsD. L. Stippel1
  • 1Klinik und Poliklinik für Visceral- und Gefäßchirurgie, Universität zu Köln
Further Information

Publication History

Publication Date:
27 August 2007 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Die wachsende klinische Bedeutung der Radiofrequenz induzierten Ablation an der Leber wird begleitet von einer schnell zunehmenden Zahl an Publikationen. Im experimentellen Bereich liegt ein besonderes Augenmerk darauf Faktoren zu definieren, die die Variabilität der Nekroseausdehnung reduzieren. Das Pringle-Manöver steht hier für den Chirurgen an erster Stelle. Die Lokalrezidivrate steigt in großen Einzelserien und einer Metaanalyse bei einem Tumordurchmesser > 3 cm drastisch an. Ein offen chirurgischer Zugang ist mit einer signifikant geringeren Lokalrezidivrate nach RFA verbunden. Gallenwegsschäden und intrahepatische Abszesse sind die häufigsten Komplikationen. Die intraduktale Gallenwegskühlung vermindert experimentell und klinisch die Häufigkeit dieser Komplikationen. Die Indikation zur RFA ist bei hepatozellulären Karzinomen durch 3 prospektive, randomisierte Studien gesichert. Für die Indikation bei kolorektalen Metastasen liegen Einzelserien bei Patienten mit multiplen Metastasen und einem 3-Jahres-Überleben > 35 % vor. In zukünftigen multimodalen Therapiekonzepten wird die RFA aufgrund der günstigen Kosten / Nutzen-Relation einen im Detail noch zu definierenden Platz einnehmen.

Abstract

The growing clinical impact of radiofrequency ablation of liver lesions is reflected by a rapidly increasing number of published papers. Experimental work focuses on factors that reduce the variability of the ablation zone. The Pringle-maneuver plays a key role in this question from a surgeon's perspective. Large single center studies and a meta-analysis show a sharp rise in the rate of local recurrences for tumors larger 3 cm. An open surgical approach is significantly correlated to a low local recurrence rate. Bile duct lesions and intrahepatic abscesses are the most frequent complications. Intraductal bile duct cooling can prevent these complications. Three prospective randomized trials support the use of RFA for small hepatocellular carcinoma. The use of RFA in patients with multiple colorectal metastases is supported by single center studies showing a 3 year survival of > 35 %. The favourable cost / benefit ratio will make RFA a part of future multimodal cancer therapy concepts.

Schlüsselwörter

Lebermetastase - Leberzellkarzinom - RFA - Zugang - Patientenüberleben

Key words

liver metastasis - primary liver cancer - RFA - approach - outcome

Literatur

  • 1 Abdalla E K, Vauthey J N, Ellis L M, Ellis V, Pollock R, Broglio K R, Hess K, Curley S A. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection / ablation for colorectal liver metastases.  Ann Surg. 2004;  239 818-825
    CrossrefPubMedGoogle Scholar
  • 2 Ahmed M, Liu Z, Afzal K S, Weeks D, Lobo S M, Kruskal J B, Lenkinski R E, Goldberg S N. Radiofrequency ablation: effect of surrounding tissue composition on coagulation necrosis in a canine tumor model.  Radiology. 2004;  230 761-767
    CrossrefPubMedGoogle Scholar
  • 3 Bangard C, Gossmann A, Kasper H U, Hellmich M, Fischer J H, Holscher A H, Lackner K, Stippel D L. Experimental radiofrequency ablation near the portal and the hepatic veins in pigs: differences in efficacy of a monopolar ablation system.  J Surg Res. 2006;  (im Druck)
    PubMedGoogle Scholar
  • 4 Berber E, Pelley R, Siperstein A E. Predictors of survival after radiofrequency thermal ablation of colorectal cancer metastases to the liver: a prospective study.  J Clin Oncol. 2005;  23 1358-1364
    CrossrefPubMedGoogle Scholar
  • 5 Cervone A, Sardi A, Conaway G L. Intraoperative ultrasound (IOUS) is essential in the management of metastatic colorectal liver lesions.  Am Surg. 2000;  66 611-615
    PubMedGoogle Scholar
  • 6 Chang C K, Hendy M P, Smith J M, Recht M H, Welling R E. Radiofrequency ablation of the porcine liver with complete hepatic vascular occlusion.  Ann Surg Oncol. 2002;  9 594-598
    PubMedGoogle Scholar
  • 7 Elias D, Baton O, Sideris L, Boige V, Malka D, Liberale G, Pocard M, Lasser P. Hepatectomy plus intraoperative radiofrequency ablation and chemotherapy to treat technically unresectable multiple colorectal liver metastases.  J Surg Oncol. 2005;  90 36-42
    Google Scholar
  • 8 Elias D, Sideris L, Pocard M, de Baere T, Dromain C, Lassau N, Lasser P. Incidence of unsuspected and treatable metastatic disease associated with operable colorectal liver metastases discovered only at laparotomy (and not treated when performing percutaneous radiofrequency ablation).  Ann Surg Oncol. 2005;  12 298-302
    CrossrefPubMedGoogle Scholar
  • 9 Elias D, Sideris L, Pocard M, Dromain C, De Baere T. Intraductal cooling of the main bile ducts during radiofrequency ablation prevents biliary stenosis.  J Am Coll Surg. 2004;  198 717-721
    Google Scholar
  • 10 Fong Y, Fortner J, Sun R L, Brennan M F, Blumgart L H. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases.  Ann Surg. 1999;  230 309-318
    CrossrefPubMedGoogle Scholar
  • 11 Germer C T, Buhr H J, Isbert C. Nonoperative ablation for liver metastases. Possibilities and limitations as a curative treatment.  Chirurg. 2005;  76 552-563
    CrossrefPubMedGoogle Scholar
  • 12 Gillams A R. The use of radiofrequency in cancer.  Br J Cancer. 2005;  92 1825-1829
    CrossrefPubMedGoogle Scholar
  • 13 Gillams A R, Lees W R. Radiofrequency ablation of colorectal liver metastases.  Abdom Imaging. 2005;  30 419-426
    CrossrefPubMedGoogle Scholar
  • 14 Goldberg S N. Science to practice: can we differenziate residual untreated tumor from tissue responses to heat following thermal tumor ablation?.  Radiology. 2005;  234 317-318
    CrossrefPubMedGoogle Scholar
  • 15 Goldberg S N, Gazelle G S, Dawson S L, Rittman W J, Mueller P R, Rosenthal D I. Tissue ablation with radiofrequency using multiprobe arrays.  Acad Radiol. 1995;  2 670-674
    PubMedGoogle Scholar
  • 16 Goldberg S N, Gazelle G S, Dawson S L, Rittman W J, Mueller P R, Rosenthal D I. Tissue ablation with radiofrequency: effect of probe size, gauge, duration, and temperature on lesion volume.  Acad Radiol. 1995;  2 399-404
    CrossrefPubMedGoogle Scholar
  • 17 Goldberg S N, Gazelle G S, Halpern E F, Rittman W J, Mueller P R, Rosenthal D I. Radiofrequency tissue ablation: importance of local temperature along the electrode tip exposure in determining lesion shape and size.  Acad Radiol. 1996;  3 212-218
    CrossrefPubMedGoogle Scholar
  • 18 Goldberg S N, Grassi C J, Cardella J F, Charboneau J W, Dodd G D, Dupuy D E, Gervais D, Gillams A R, Kane R A, Lee F T, Livraghi T, McGahan J, Phillips D A, Rhim H, Silverman S G. Image-guided tumor ablation: standardization of terminology and reporting criteria.  Radiology. 2005;  235 728-739
    CrossrefPubMedGoogle Scholar
  • 19 Hansen P D, Rogers S, Corless C L, Swanstrom L L, Siperstien A E. Radiofrequency ablation lesions in a pig liver model.  J Surg Res. 1999;  87 114-121
    CrossrefPubMedGoogle Scholar
  • 20 Investigators C. Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. The Cancer of the Liver Italian Program (CLIP) Investigators.  Hepatology. 2000;  31 840-845
    CrossrefPubMedGoogle Scholar
  • 21 Jansen M C, van Hillegersberg R, Chamuleau R A, van Delden O M, Gouma D J, van Gulik T M. Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective review.  Eur J Surg Oncol. 2005;  31 331-347
    CrossrefPubMedGoogle Scholar
  • 22 Karmali S, Dixon E. Biliary stricture resulting from radiofrequency ablation.  Am J Surg. 2004;  188 76-77
    PubMedGoogle Scholar
  • 23 Kim S H, Lim H K, Choi D, Lee W J, Kim M J, Lee S J, Lim J H. Changes in bile ducts after radiofrequency ablation of hepatocellular carcinoma: frequency and clinical significance.  AJR Am J Roentgenol. 2004;  183 1611-1617
    CrossrefPubMedGoogle Scholar
  • 24 Lencioni R A, Allgaier H P, Cioni D, Olschewski M, Deibert P, Crocetti L, Frings H, Laubenberger J, Zuber I, Blum H E, Bartolozzi C. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection.  Radiology. 2003;  228 235-240
    CrossrefPubMedGoogle Scholar
  • 25 Lin S M, Lin C J, Lin C C, Hsu C W, Chen Y C. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less.  Gut. 2005;  54 1151-1156
    CrossrefPubMedGoogle Scholar
  • 26 Lu D S, Yu N C, Raman S S, Limanond P, Lassman C, Murray K, Tong M J, Amado R G, Busuttil R W. Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver.  Radiology. 2005;  234 954-960
    CrossrefPubMedGoogle Scholar
  • 27 Marchal F, Elias D, Rauch P, Zarnegar R, Leroux A, Stines J, Verhaeghe J L, Guillemin F, Carteaux J P, Villemot J P. Prevention of biliary lesions that may occur during radiofrequency ablation of the liver: study on the pig.  Ann Surg. 2006;  243 82-88
    CrossrefPubMedGoogle Scholar
  • 28 Mazzaferro V, Battiston C, Perrone S, Pulvirenti A, Regalia E, Romito R, Sarli D, Schiavo M, Garbagnati F, Marchiano A, Spreafico C, Camerini T, Mariani L, Miceli R, Andreola S. Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study.  Ann Surg. 2004;  240 900-909
    CrossrefPubMedGoogle Scholar
  • 29 Montgomery R S, Rahal A, Dodd G D, Leyendecker J R, Hubbard L G. Radiofrequency ablation of hepatic tumors: variability of lesion size using a single ablation device.  AJR Am J Roentgenol. 2004;  182 657-661
    PubMedGoogle Scholar
  • 30 Mulier S, Mulier P, Ni Y, Miao Y, Dupas B, Marchal G, De Wever I, Michel L. Complications of radiofrequency coagulation of liver tumours.  Br J Surg. 2002;  89 1206-1222
    CrossrefPubMedGoogle Scholar
  • 31 Mulier S, Ni Y, Jamart J, Ruers T, Marchal G, Michel L. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors.  Ann Surg. 2005;  242 158-171
    CrossrefPubMedGoogle Scholar
  • 32 Mulier S, Ni Y, Miao Y, Rosiere A, Khoury A, Marchal G, Michel L. Size and geometry of hepatic radiofrequency lesions.  Eur J Surg Oncol. 2003;  29 867-878
    CrossrefPubMedGoogle Scholar
  • 33 Ng K K, Lam C M, Poon R T, Shek T W, Fan S T, Wong J. Delayed portal vein thrombosis after experimental radiofrequency ablation near the main portal vein.  Br J Surg. 2004;  91 632-639
    CrossrefPubMedGoogle Scholar
  • 34 Patterson E J, Scudamore C H, Owen D A, Nagy A G, Buczkowski A K. Radiofrequency ablation of porcine liver in vivo: effects of blood flow and treatment time on lesion size.  Ann Surg. 1998;  227 559-565
    CrossrefPubMedGoogle Scholar
  • 35 Pawlik T M, Izzo F, Cohen D S, Morris J S, Curley S A. Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients.  Ann Surg Oncol. 2003;  10 1059-1069
    CrossrefPubMedGoogle Scholar
  • 36 Pereira P L, Trubenbach J, Schenk M, Subke J, Kroeber S, Schaefer I, Remy C T, Schmidt D, Brieger J, Claussen C D. Radiofrequency ablation: in vivo comparison of four commercially available devices in pig livers.  Radiology. 2004;  232 482-490
    CrossrefPubMedGoogle Scholar
  • 37 Pompili M, Mirante V G, Rondinara G, Fassati L R, Piscaglia F, Agnes S, Covino M, Ravaioli M, Fagiuoli S, Gasbarrini G, Rapaccini G L. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence.  Liver Transpl. 2005;  11 1117-1126
    CrossrefPubMedGoogle Scholar
  • 38 Poon R T, Ng K K, Lam C M, Ai V, Yuen J, Fan S T, Wong J. Learning curve for radiofrequency ablation of liver tumors: prospective analysis of initial 100 patients in a tertiary institution.  Ann Surg. 2004;  239 441-449
    CrossrefPubMedGoogle Scholar
  • 39 Rhim H. Complications of radiofrequency ablation in hepatocellular carcinoma.  Abdom Imaging. 2005;  30 409-418
    CrossrefPubMedGoogle Scholar
  • 40 Santambrogio R, Podda M, Zuin M, Bertolini E, Bruno S, Cornalba G P, Costa M, Montorsi M. Safety and efficacy of laparoscopic radiofrequency ablation of hepatocellular carcinoma in patients with liver cirrhosis.  Surg Endosc. 2003;  17 1826-1832
    CrossrefPubMedGoogle Scholar
  • 41 Shiina S, Teratani T, Obi S, Sato S, Tateishi R, Fujishima T, Ishikawa T, Koike Y, Yoshida H, Kawabe T, Omata M. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma.  Gastroenterology. 2005;  129 122-130
    CrossrefPubMedGoogle Scholar
  • 42 Siperstein A, Garland A, Engle K, Rogers S, Berber E, String A, Foroutani A, Ryan T. Laparoscopic radiofrequency ablation of primary and metastatic liver tumors. Technical considerations.  Surg Endosc. 2000;  14 400-405
    CrossrefPubMedGoogle Scholar
  • 43 Solazzo S A, Liu Z, Lobo S M, Ahmed M, Hines-Peralta A U, Lenkinski R E, Goldberg S N. Radiofrequency ablation: importance of background tissue electrical conductivity - an agar phantom and computer modeling study.  Radiology. 2005;  236 495-502
    CrossrefPubMedGoogle Scholar
  • 44 Stippel D L, Bangard C, Kasper H U, Fischer J H, Holscher A H, Gossmann A. Experimental bile duct protection by intraductal cooling during radiofrequency ablation.  Br J Surg. 2005;  92 849-855
    CrossrefPubMedGoogle Scholar
  • 45 Stippel D L, Brochhagen H G, Arenja M, Hunkemoller J, Holscher A H, Beckurts K T. Variability of size and shape of necrosis induced by radiofrequency ablation in human livers: a volumetric evaluation.  Ann Surg Oncol. 2004;  11 420-425
    CrossrefPubMedGoogle Scholar
  • 46 Stippel D L, Tox U, Gossmann A, Beckurts K T, Holscher A H. Successful treatment of radiofrequency-induced biliary lesions by interventional endoscopic retrograde cholangiography (ERC).  Surg Endosc. 2003;  17 1965-1970
    CrossrefPubMedGoogle Scholar
  • 47 Wiersinga W J, Jansen M C, Straatsburg I H, Davids P H, Klaase J M, Gouma D J, Van Gulik T M. Lesion progression with time and the effect of vascular occlusion following radiofrequency ablation of the liver.  Br J Surg. 2003;  90 306-312
    CrossrefPubMedGoogle Scholar

Priv.-Doz. Dr. D. L. Stippel

Klinik und Poliklinik für Visceral- und Gefäßchirurgie

Joseph-Stelzmann-Straße 9

50931 Köln

Phone: +49/2 21/4 78 50 77

Fax: +49/2 21/4 78 62 58

Email: Dirk.Stippel@uni-koeln.de